bluebird bio and TC BioPharm announce strategic collaboration
bluebird bio announced a strategic collaboration and license agreement focused on gamma delta CAR T cells. The companies will work together to advance TC BioPharm’s lead CAR-engineered gamma delta T cell program into clinical trials as well as on additional hematologic and solid tumor targets. December 07, 2017